THIRUVANANTHAPURAM:
Ahead of the crucial meeting of the GST Council on Thursday, November 3, a cohort of victims, doctors and economists have banded together to appeal to the Council for the inclusion of all tobacco products in the highest tax slab.
The proposed ‘sin tax’ rate of 26 per cent would be detrimental to both public health and the national economy, they argue. The proposed rates would make tobacco products more affordable, thereby boosting consumption and leading to an increase in the incidence of grave, even terminal, conditions, including cardiovascular diseases and cancers. In addition, they point out that the revenue from tobacco products would be significantly reduced.
Saju, a tobacco-induced oral cancer victim, says that the prices of all tobacco products should be kept high to both dissuade current users and prevent the initiation of new users. “I smoked my first cigarette in my early 20s. Gradually, I was drawn to smoking and I would smoke three-four cigarettes in addition to using smokeless tobacco products,” he said.
Tobacco use made Saju an oral cancer patient at the young age of 30. He was treated with chemotherapy, surgery and radiation at Vandanam Medical College, Alappuzha, and is on regular follow-ups. The treatment spread over a year cost around Rs three lakh.
“When I think back, I ask myself why I spent my hard-earned money on tobacco products. It gave my family and me only suffering and trauma. No one should have to undergo the pain and stress I suffered,” said Saju, who is now in his early 30s.
Dr Tiny Nair, Head of the Department of Cardiology, PRS Hospital, has long campaigned for imposing the highest tax rates on tobacco products. He said, “Taxing tobacco products is a proven way to reduce consumption as WHO studies have shown. A lower GST rate can accentuate the tobacco epidemic, driving up healthcare costs. The GST Council should tax all smoking and smokeless tobacco products at the highest rate. This way, irreplaceable lives can be safeguarded from untimely morbidity and mortality.”
According to Dr Rijo John, Assistant Professor, IIT Jodhpur, “Compared to a GST sin tax rate of 40 per cent, imposing a 26 per cent sin rate would reduce total tobacco tax revenue by almost one-fifth (17 per cent, or roughly Rs 10,510 crore) even if the government retains the current excise on tobacco products post GST.”
“Clearly, a 26 per cent sin rate will be well below the rate required to maintain a revenue neutral position for tobacco and will significantly reduce tax burden on all tobacco products since the existing average VAT rates themselves are higher than 26 per cent on most tobacco products,” adde
d Dr John, a reputed researcher on tobacco taxation.
The rationale for a sin tax is two-fold, to pay for the damage caused to society by products like tobacco and second, to reduce usage by increasing price. A 40 per cent sin tax rate combined with the existing excise tax and top-up state taxes on tobacco appears to be the best scenario for public health and revenue.
more recommended stories
A Doctor’s Touch, Twice BlessedKOCHI:Dr. Mathew Jacob was all smiles.
Aster Medcity Hosts Scoliosis Diagnosis CampKOCHI:Aster Spine Centre at Aster Medcity.
Minister Mohamed Riyas to Inaugurate EMAK Silent Heroes Awards 2025KOLLAM:The seventh edition of The Silent.
National Conclave on CAR-T Cell Therapy Held in KochiKOCHI:Dr. Divya S. Iyer, Managing Director.
Summer Camp for School Children Gets UnderwayTHIRUVANANTHAPURAM:The second edition of six-day ‘Kalapila.
Aster Medcity Observes World Autism Awareness Day 2025KOCHI:Aster Medcity celebrated World Autism Awareness.
Milma’s TRCMPU Announced Additional Milk Rate of Rs 16 per LitreTHIRUVANANTHAPURAM:Milma’s Thiruvananthapuram Regional Co-operative Milk Producers’.
Revolutionary Cardiac Milestone Funded by Manipal Foundation CSRKOLKATA:In a rarest of rare case.
Drug Free Kerala: MLAs Play Friendly Cricket Match at TechnoparkTHIRUVANANTHAPURAM:Raising the pitch against drug abuse,.
Aster Medcity Organizes ‘Traumax-2025’ to Promote Care of Trauma VictimKOCHI:Aster Medcity organized TRAUMAX 2025, a.